CoQmax Ubiquinol 60 sg by Xymogen
If you are looking for an effective antioxidant supplement, CoQmax Ubiquinol 60sg will be a good choice.* Formulated by Xymogen, this product contains a bioactive form of CoQ10 that may neutralize harmful free radicals and superoxides.*
Who Should Consider CoQmax Ubiquinol 60 softgels?
CoQmax Ubiquinol 60sg may support your health if you:
- suffer from muscle pain and fatigue*
- are over 40 years old*
- are an athlete wanting to improve your endurance*
How May CoQmax Ubiquinol 60sg by Xymogen Support Your Health?
CoQmax Ubiquinol 60sg may offer the following benefits:
- improved antioxidant activity in lymph, blood, and cell membranes*
- neutralization of superoxide and other free radicals*
- enhanced ubiquinol levels for aging individuals*
Supplements support your health but do not replace a balanced diet. Always check with your healthcare practitioner if you have doubts about a new supplement. Book a FREE product consultation to learn more about CoQmax Ubiquinol 60 softgels by Xymogen.
Recommendation:
Xymogen recommends taking 1-2 CoQmax Ubiquinol softgels daily, or as directed by your health care practitioner.
Supplement Facts:
Serving Size: 2 softgels
Servings Per Container: 30
Amount Per Serving:
Calories 15
Total Fat 1.5 g
Coenzyme Q10 (as ubiquinol) 200 mg
Other Ingredients: Medium-chain triglycerides, softgel (bovine gelatin, glycerin, purified water, and annatto in sunflower oil), ascorbyl palmitate, white beeswax, and sunflower lecithin.
Does Not Contain: Wheat, gluten, corn, yeast, soy, dairy products, fish, shellfish, peanuts, tree nuts, egg, ingredients derived from genetically modified organisms (GMOs), artificial colors, artificial sweeteners, or artificial preservatives.
Warnings:
Consult your healthcare practitioner prior to use. Individuals taking medication or receiving cancer treatment should discuss potential interactions with their healthcare practitioner.
Storage:
Keep closed in a cool, dry place out of reach of children.
* The statements have not been evaluated by the Food and Drug Administration.
Products listed are not intended to diagnose, treat, cure, or prevent disease.
© 2012 2014 XYMOGEN®
LEGAL NOTICE: Xymogen's Exclusive Professional Formulas are available through select licensed health care professionals. The Internet Sale and Discounting of XYMOGEN formulas are strictly prohibited. covenanthealthproducts.com makes XYMOGEN formulas available only to patients of our clinic. If you are a patient of covenanthealthproducts.com, you may inquire about XYMOGEN by calling (800) 627-6518
References:
- Cathcart, M. K., McNally, A. K., Morel, D. W., et al. (1989). Superoxide anion participation in human monocyte-mediated oxidation of low-density lipoprotein and conversion of low-density lipoprotein to a cytotoxin. Journal of Immunology, 142(6), 1963–1969. [PMID: 2537865]
- Crane, F. L. (2001). Biochemical functions of coenzyme Q10. Journal of the American College of Nutrition, 20(6), 591–598. [PMID: 11771674]
- Hosoe, K., Kitano, M., Kishida, H., et al. (2007). Study on safety and bioavailability of ubiquinol (Kaneka QH) after single and 4-week multiple oral administration to healthy volunteers. Regulatory Toxicology and Pharmacology, 47(1), 19–28. [PMID: 16919858]
- Kaneka QH™ Ubiquinol. (2011). Retrieved December 15, 2011, from http://www.kanekaqh.com
- Langsjoen, P. H., & Langsjoen, A. M. (2003). The clinical use of HMG CoA-reductase inhibitors and the associated depletion of coenzyme Q10: A review of animal and human publications. Biofactors, 18(1-4), 101–111. [PMID: 14695925]
- Langsjoen, P. H., & Langsjoen, A. M. (2008). Supplemental ubiquinol in patients with advanced congestive heart failure. Biofactors, 32(1-4), 119–128. [PMID: 19096107]
- Passi, S., Stancato, A., Aleo, E., et al. (2003). Statins lower plasma and lymphocyte ubiquinol/ubiquinone without affecting other antioxidants and PUFA. Biofactors, 18(1-4), 113–124. [PMID: 14695926]
- Rosenfeldt, F. L., Pepe, S., Ou, R., et al. (1999). Coenzyme Q10 improves the tolerance of the senescent myocardium to aerobic and ischemic stress: Studies in rats and in human atrial tissue. Biofactors, 9(2-4), 291–299. [PMID: 10416043]
- Schmelzer, C., Kubo, H., Mori, M., et al. (2010). Supplementation with the reduced form of Coenzyme Q10 decelerates phenotypic characteristics of senescence and induces a peroxisome proliferator-activated receptor-alpha gene expression signature in SAMP1 mice. Molecular Nutrition & Food Research, 54(6), 805–815. [PMID: 19960455]
- Yan, J., Fujii, K., Yao, J., et al. (2006). Reduced coenzyme Q10 supplementation decelerates senescence in SAMP1 mice. Experimental Gerontology, 41(2), 130–140. [PMID: 16387461]